J Garry Sack, MD | |
2801 Westhill Dr, Wausau, WI 54401-3700 | |
(715) 847-2021 | |
(715) 847-2325 |
Full Name | J Garry Sack |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Location | 2801 Westhill Dr, Wausau, Wisconsin |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205889565 | NPI | - | NPPES |
30108700 | Medicaid | WI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | 18475-020 (Wisconsin) | Primary |
Mailing Address | Practice Location Address |
---|---|
J Garry Sack, MD 2801 Westhill Dr, Wausau, WI 54401-3700 Ph: (715) 847-2021 | J Garry Sack, MD 2801 Westhill Dr, Wausau, WI 54401-3700 Ph: (715) 847-2021 |
News Archive
What causes a virus to suddenly begin infecting large numbers of people? Scientists have long known that the process they call "viral emergence" involves a wide variety of factors. Some are changes in the environment, either generated by natural causes or human activity. Others are internal, arising from accidental changes - mutations -in the virus' genetic code.
Intrasphere Technologies, a Drug Safety specialized consulting and solutions firm that provides services to Life Sciences organizations, today announced that it has launched SafetyXpress. SafetyXpress for Argus is Intrasphere's proprietary implementation accelerator framework for the rapid deployment of the Argus Safety suite. Intrasphere is a Specialized Oracle Argus Safety Gold Partner.
In a comprehensive analysis comparing nurse staffing in California hospitals to similar hospitals in the U.S. over nearly a decade, researchers at the University of Pennsylvania School of Nursing have found that controversial legislation setting nurse-to-patient ratios added more registered nurses to the hospital staffing mix, not fewer as feared.
In anticipation of the AIDS 2012 conference, to be held in Washington, D.C., from July 22-27, CDC Director Thomas Frieden spoke at the Washington-based Center for Strategic & International Studies, where he provided an update on the epidemic in the U.S. and abroad, VOA News reports.
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (EURONEXT: SAN and NYSE: SNY) today announced that a Phase 2a proof-of-concept study of dupilumab, an investigational therapy that blocks IL-4 and IL-13 signaling, met all primary and secondary endpoints in patients with moderate-to-severe chronic sinusitis with nasal polyps (CSwNP) who did not respond to intranasal corticosteroids.
› Verified 2 days ago
Dr. Jessica Ann Weddle, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 512 S 28th Ave, Wausau, WI 54401 Phone: 715-847-2020 Fax: 715-847-2325 | |
Gregory K Sewall, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 512 S 28th Ave, Wausau, WI 54401 Phone: 715-847-2021 Fax: 715-847-2325 | |
Sarvi S Nalwa, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 512 S 28th Ave, Wausau, WI 54401 Phone: 715-847-2021 Fax: 715-847-2325 | |
Rocky A Lipsman, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 2801 Westhill Dr, Wausau, WI 54401 Phone: 715-847-2021 Fax: 715-847-2325 | |
Mark A Voss, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 512 S 28th Ave, Wausau, WI 54401 Phone: 715-847-2021 Fax: 715-847-2325 |